Skip to Content
Uncategorized

For the First Time, Gene Editing Is Taking Place Inside the Human Body

November 15, 2017

A man named Brian Madeux has just become a walking experiment. He’s the first human to officially have gene editing take place inside his body, thanks to an IV packed with snippets of DNA and the means to insert them into his own genetic material.

The Associated Press reports that the treatment, developed by Sangamo Therapeutics, uses a technique known as zinc fingers to snip Madeux’s DNA and insert a corrective gene. If all goes to plan, that will allow his body to produce enzymes that counter his liver condition, Hunter syndrome. He’ll be dearly hoping that it does, because to date he’s had 26 operations to fix problems caused by his illness.

Gene editing has, of course, made it into humans before. Sangamo has developed previous treatments, such as one for HIV, in which cells are harvested, genetically engineered, and transfused back into the patient. But this is the first time gene editing has actually taken place in the human body. Scientists are still developing trials that will introduce the CRISPR gene-editing tool into the body.

Even more than is the case with most treatments, there’s little turning back from gene editing as a cure, because it permanently changes a person’s DNA. That means that if the therapy goes as intended, it will provide a lasting effect for the patient—but if the technique edits the DNA incorrectly, things could go badly wrong. That’s why attempts to perform DIY gene editing in home-brew labs are so damn risky (see “One Man’s Quest to Hack His Own Genes”).

In three months Madeux will undergo tests to determine whether the procedure has worked properly. “I’m nervous and excited,” he told the Associated Press. “I’m willing to take that risk. Hopefully it will help me and other people.”

Keep Reading

Most Popular

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

It’s time to retire the term “user”

The proliferation of AI means we need a new word.

The problem with plug-in hybrids? Their drivers.

Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.

Sam Altman says helpful agents are poised to become AI’s killer function

Open AI’s CEO says we won’t need new hardware or lots more training data to get there.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.